Julie V. Early - Concepedia

Author

Julie V. Early

Infectious Disease Research Institute

Also Known As

J. EARLY, J. Early, Julie Early, Julie V. Early, Lia Danelishvili

Publications

733

Citations

H-Index

Concepts

All Affiliations

Infectious Disease Research Institute Eli Lilly (United States)Jubilant Life Sciences (India)Cornell University Oregon State University

About

Julie V. Early is an author at Infectious Disease Research Institute specializing in medicine, tuberculosis, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	373
2	Biochemistry	6	6	196
3	Natural Sciences	4	4	142
4	Health Sciences	2	2	80
5	Engineering	1	1	18

Julie V. Early

Publications

564

Citations

H-Index

Page 1

	Year	Citations
Mycobacterium avium uses apoptotic macrophages as tools for spreading Julie V. Early, Kay A. Fischer, Luiz E. Bermudez Microbial Pathogenesis Pulmonary TuberculosisMycobacterium AviumTuberculosisMicrobiologyInfection Control	2010	66
Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents Edward A. Kesicki, Mai A. Bailey, Yulia Ovechkina, PLoS ONE Anti-tubercular AgentsBioorganic ChemistryPharmacotherapyHeterocycle ChemistryDrug Resistance	2016	57
Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels Theresa O’Malley, Torey Alling, Julie V. Early, Antimicrobial Agents and Chemotherapy	2018	54
Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979 J. Oluoch Odingo, Theresa O’Malley, Edward A. Kesicki, Medicinal Chemistry 22Medicinal ChemistryBioorganic ChemistryBiochemistryNatural Sciences	2014	52
Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity N. Susantha Chandrasekera, Torey Alling, Mai A. Bailey, Journal of Medicinal Chemistry Medicinal ChemistryAntitubercular ActivityPulmonary TuberculosisBiochemistryMedicine	2015	43
Identification of Compounds with pH-Dependent Bactericidal Activity against <i>Mycobacterium tuberculosis</i> Julie V. Early, Juliane Ollinger, Crystal M. Darby, ACS Infectious Diseases Bioorganic ChemistryAntibiotic AdjuvantAntimicrobial ChemotherapyPh HomeostasisDrug Resistance	2018	35
Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents Joshua Odingo, Theresa O’Malley, Edward A. Kesicki, Bioorganic & Medicinal Chemistry	2014	33
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth Peter C. Ray, Margaret Huggett, Penelope A. Turner, ACS Omega	2021	33
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis Julie V. Early, Allen Casey, A. MARTINEZ‐GRAU, Antimicrobial Agents and Chemotherapy Pulmonary TuberculosisAntimicrobial Drug DiscoveryCarbon Source AvailabilityBiochemistryMedicine	2016	31
In Vitro Evaluation of Novel Nitazoxanide Derivatives against <i>Mycobacterium tuberculosis</i> Joshua Odingo, Mai A. Bailey, Megan Files, ACS Omega	2017	29

Page 1